Shattuck Labs Jumps 26% on OrbiMed Investment
Shattuck Labs, Inc. (STTK) surged 26.24% to lead the PRISM Emerging Biotech Index after OrbiMed Advisors disclosed the purchase of over 6.3 million shares at $0.8677 per share, totaling $5.47 million. The investment made alongside pre-funded and common warrant acquisitions, highlights institutional confidence in Shattuck’s immunotherapy pipeline.
Biotricity Rises 23% on Expansion into Consumer Wearables
Biotricity Inc. (BTCY) gained 23.31%, boosting the PRISM Emerging Healthcare Index, after announcing a major expansion of its next-gen cardiac monitoring platform with partner B-Secur. The enhancement will integrate ECG data from consumer wearables, including smartwatches, fitness trackers, and smart rings, into Biotricity’s cloud-based medical workflow. Leveraging B-Secur’s FDA-cleared HeartKey algorithms, the device-agnostic platform bridges consumer health products with clinical-grade monitoring.
Other PRISM Mid-Day Movers:
The post PRISM Mid-Day Movers: Share Purchases and Wearables Innovation Drive Index Gains appeared first on PRISM MarketView.
